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Purpose
Preclinical studies have demonstrated that intraprostatic/
intratumoral (IT) administration of vaccine in combina-
tion with systemic vaccination (SC) may improve antitu-
mor efficacy. In this study we assessed the differential
effects of IT/SC vaccination in peripheral blood mononuc-
lear cells (PBMCs) and tumor-infiltrating lymphocytes
(TILs).
Methods
Measurements were performed before and near day 113
post IT/SC administration of PSA-TRICOM vaccine in 21
patients (pts) with locally recurrent or progressive prostate
cancer (PC) enrolled in a dose-escalation phase 1 trial. Pts
received initial SC vaccination with recombinant vaccinia-
PSA-TRICOM and IT boosts with recombinant fowlpox
(rF)-PSA-TRICOM. Cohort 3-5 received intraprostatic
rF-GM-CSF. Cohort 5 received SC boosts with rF-PSA-
TRICOM and rF-GM-CSF. We evaluated Treg suppres-
sion, NK function, and frequencies of immune cell subsets
from PBMC by flow-cytometry. TILs were measured by
digital immunohistochemistry (IHC). Prostate cores were
obtained by transrectal ultrasound-guided biopsies. Pros-
tate sections were stained for CD4, CD8, FoxP3, or isotype
controls. Digital IHC images were acquired with an Aperio
ScanScope AT Turbo and analyzed with the Aperio
ImageScope membrane algorithm for cell membrane
analysis. CD4+ TILs positive for FoxP3 (putative Tregs)
were counted manually.
Results
The function of Treg and NK cells isolated from PBMC,
as well as circulating immune cell subsets, did not change
after vaccine. A lower percentage of circulating Tregs
post-vaccine correlated with decreases in serum PSA
(P=0.002, R=0.67). There was an inverse correlation
between CD4+PBMCs and CD4+ TILs post-vaccine
(p=0.010, R=-0.61). CD4+ and CD8+ TILs increased post-
vaccine (p<0.001 for both) independently of hormone
status and GM-CSF treatment. Pts with low CD4+ TILs
pre-vaccine showed a greater increase in CD4+ TILs
post-vaccine (27 vs. 3 fold-change, respectively, p=0.002).
Tregs (as % of CD4+ TILs) decreased post-vaccine
(p<0.001). There was also a correlation between CD8+
TILs increase post-vaccine and decreases in serum PSA
(p=0.002, R=-0.83).
Conclusions
The use of digital IHC after IT/SC vaccination can help to
document variations of immune infiltration and clinical
correlates in the absence of relevant changes in PBMC
immune cell subsets.
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